Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 3853409, 17 pages
https://doi.org/10.1155/2018/3853409
Research Article

Proscillaridin A Promotes Oxidative Stress and ER Stress, Inhibits STAT3 Activation, and Induces Apoptosis in A549 Lung Adenocarcinoma Cells

1College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning 116044, China
2Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning 116044, China

Correspondence should be addressed to Muhammad Khan; moc.liamy@tsigolooz_nahk and Tonghui Ma; nc.ude.udemld@amiuhgnot

Received 26 July 2017; Revised 21 October 2017; Accepted 16 November 2017; Published 11 January 2018

Academic Editor: Javier Egea

Copyright © 2018 Amara Maryam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Li, J. Huang, X. D. Zhou, W. B. Zhang, Y. T. Lai, and G. W. Che, “Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis,” Journal of Thoracic Disease, vol. 8, no. 7, pp. 1587–1600, 2016. View at Publisher · View at Google Scholar
  2. Y. Abe and N. Tanaka, “The hedgehog signaling networks in lung cancer: the mechanisms and roles in tumor progression and implications for cancer therapy,” BioMed Research International, vol. 2016, Article ID 7969286, 11 pages, 2016. View at Publisher · View at Google Scholar
  3. B. Li, J. You, T. Huang, and Y. D. Cai, “Classification of non-small cell lung cancer based on copy number alterations,” PLoS One, vol. 9, no. 2, article e88300, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. G. H. Dai, G. M. Meng, Y. L. Tong et al., “Growth-inhibiting and apoptosis-inducing activities of Myricanol from the bark of Myrica rubra in human lung adenocarcinoma A549 cells,” Phytomedicine, vol. 21, no. 11, pp. 1490–1496, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Zer and N. Leighl, “Promising targets and current clinical trials in metastatic non-squamous NSCLC,” Frontiers in Oncology, vol. 4, p. 329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Köhler and M. Schuler, “Afatinib, erlotinib and gefitinib in the first-line therapy of EGFR mutation-positive lung adenocarcinoma: a review,” Onkologie, vol. 36, no. 9, pp. 510–518, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Yu, Y. Xiong, and C. Wang, “Bu-Zhong-Yi-qi decoction, the water extract of Chinese traditional herbal medicine, enhances cisplatin cytotoxicity in A549/DDP cells through induction of apoptosis and autophagy,” BioMed Research International, vol. 2017, Article ID 3692797, 9 pages, 2017. View at Publisher · View at Google Scholar
  8. Y. Jia, C. H. Yun, E. Park et al., “Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors,” Nature, vol. 534, no. 7605, pp. 129–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Wu, Q. Chang, Y. Lu et al., “Gefitinib resistance resulted from STAT3-mediated Akt activation in lung cancer cells,” Oncotarget, vol. 4, no. 12, pp. 2430–2438, 2013. View at Publisher · View at Google Scholar
  10. J. H. Lee, C. Kim, G. Sethi, and K. S. Ahn, “Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxel,” Oncotarget, vol. 6, no. 8, pp. 6386–6405, 2015. View at Publisher · View at Google Scholar
  11. M. Khan, A. Maryam, J. I. Qazi, and T. Ma, “Targeting apoptosis and multiple signaling pathways with icariside II in cancer cells,” International Journal of Biological Sciences, vol. 11, no. 9, pp. 1100–1112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Chun, R. J. Li, M. S. Cheng, and Y. S. Kim, “Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells,” Cancer Letters, vol. 357, no. 1, pp. 393–403, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Butturini, A. Carcereri de Prati, G. Chiavegato et al., “Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs,” Free Radical Biology & Medicine, vol. 65, pp. 1322–1330, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Yue and J. Turkson, “Targeting STAT3 in cancer: how successful are we?” Expert Opinion on Investigational Drugs, vol. 18, no. 1, pp. 45–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Tang, F. Guo, Y. Du et al., “Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3,” International Journal of Oncology, vol. 46, no. 5, pp. 2083–2095, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Hu, P. Jin, and W. Liu, “Periostin contributes to cisplatin resistance in human non-small cell lung cancer A549 cells via activation of Stat3 and Akt and upregulation of survivin,” Cellular Physiology and Biochemistry, vol. 38, no. 3, pp. 1199–1208, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Cerella, M. Dicato, and M. Diederich, “Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides,” Mitochondrion, vol. 13, no. 3, pp. 225–234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Calderon-Montano, E. Burgos-Morón, M. L. Orta, D. Maldonado-Navas, I. García-Domínguez, and M. López-Lázaro, “Evaluating the cancer therapeutic potential of cardiac glycosides,” BioMed Research International, vol. 2014, Article ID 794930, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Slingerland, C. Cerella, H. J. Guchelaar, M. Diederich, and H. Gelderblom, “Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials,” Investigational New Drugs, vol. 31, no. 4, pp. 1087–1094, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. R. El-Seedi, R. Burman, A. Mansour et al., “The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: discovery of an active cardiac glycoside from Urginea maritima,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 746–757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Maryam, T. Mehmood, H. Zhang, Y. Li, M. Khan, and T. Ma, “Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress,” Scientific Reports, vol. 7, no. 1, p. 6242, 2017. View at Publisher · View at Google Scholar
  22. A. C. Wallace, R. A. Laskowski, and J. M. Thornton, “LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions,” Protein Engineering, vol. 8, no. 2, pp. 127–134, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Morris, R. Huey, W. Lindstrom et al., “AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility,” Journal of Computational Chemistry, vol. 30, no. 16, pp. 2785–2791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Mehmood, A. Maryam, H. Zhang, Y. Li, M. Khan, and T. Ma, “Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-κB inhibition and mitochondrial dysfunction,” BioFactors, vol. 43, no. 1, pp. 63–72, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. W. P. Tsang, S. P. Y. Chau, S. K. Kong, K. P. Fung, and T. T. Kwok, “Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis,” Life Sciences, vol. 73, no. 16, pp. 2047–2058, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Chen, L. Wang, H. Shen, H. Lin, and D. Li, “Anthelminthic drug niclosamide sensitizes the responsiveness of cervical cancer cells to paclitaxel via oxidative stress-mediated mTOR inhibition,” Biochemical and Biophysical Research Communications, vol. 484, no. 2, pp. 416–421, 2017. View at Publisher · View at Google Scholar
  27. E. K. Kim and E. J. Choi, “Pathological roles of MAPK signaling pathways in human diseases,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1802, no. 4, pp. 396–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Khan, C. Ding, A. Rasul et al., “Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells,” International Journal of Biological Sciences, vol. 8, no. 4, pp. 533–547, 2012. View at Publisher · View at Google Scholar
  29. Z. Ren, S. Chen, T. Qing et al., “Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells,” Toxicology, vol. 392, pp. 11–21, 2017. View at Publisher · View at Google Scholar
  30. J. S. Yu and A. K. Kim, “Platycodin D induces reactive oxygen species-mediated apoptosis signal-regulating kinase 1 activation and endoplasmic reticulum stress response in human breast cancer cells,” Journal of Medicinal Food, vol. 15, no. 8, pp. 691–699, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Khan, B. Zheng, F. Yi et al., “Pseudolaric acid B induces caspase-dependent and caspase-independent apoptosis in u87 glioblastoma cells,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 957568, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. KoraMagazi, D. Wang, B. Yousef, M. Guerram, and F. Yu, “Rhein triggers apoptosis via induction of endoplasmic reticulum stress, caspase-4 and intracellular calcium in primary human hepatic HL-7702 cells,” Biochemical and Biophysical Research Communications, vol. 473, no. 1, pp. 230–236, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Hempel and M. Trebak, “Crosstalk between calcium and reactive oxygen species signaling in cancer,” Cell Calcium, vol. 63, pp. 70–96, 2017. View at Publisher · View at Google Scholar
  34. T. Mijatovic, N. de Neve, P. Gailly et al., “Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity,” Molecular Cancer Therapeutics, vol. 7, no. 5, pp. 1285–1296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Lefranc, T. Mijatovic, Y. Kondo et al., “Targeting the α 1 subunit of the sodium pump to combat glioblastoma cells,” Neurosurgery, vol. 62, no. 1, pp. 211–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Hu, J. Han, B. Zhai et al., “Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation,” Apoptosis, vol. 19, no. 1, pp. 210–223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Khan, T. Li, M. K. Ahmad Khan et al., “Alantolactone induces apoptosis in HepG2 cells through GSH depletion, inhibition of STAT3 activation, and mitochondrial dysfunction,” BioMed Research International, vol. 2013, Article ID 719858, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Liu, J. Yang, L. Li, W. Shi, X. Yuan, and L. Wu, “The natural occurring compounds targeting endoplasmic reticulum stress,” Evidence-based Complementary and Alternative Medicine, vol. 2016, Article ID 7831282, 13 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Khoutorsky, R. E. Sorge, M. Prager-Khoutorsky et al., “eIF2α phosphorylation controls thermal nociception,” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 42, pp. 11949–11954, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. C. Tsai and A. M. Weissman, “The unfolded protein response, degradation from the endoplasmic reticulum, and cancer,” Genes & Cancer, vol. 1, no. 7, pp. 764–778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Chang and M. Karin, “Mammalian MAP kinase signalling cascades,” Nature, vol. 410, no. 6824, pp. 37–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Sui, N. Kong, L. Ye et al., “p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents,” Cancer Letters, vol. 344, no. 2, pp. 174–179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Sun, W. Z. Liu, T. Liu, X. Feng, N. Yang, and H. F. Zhou, “Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis,” Journal of Receptor and Signal Transduction Research, vol. 35, no. 6, pp. 600–604, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Nan, Y. Du, X. Chen et al., “TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers,” Molecular Cancer Therapeutics, vol. 13, no. 3, pp. 617–629, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. S. J. Kim and S. Yoon, “Activated Rac1 regulates the degradation of IκBα and the nuclear translocation of STAT3–NFκB complexes in starved cancer cells,” Experimental & Molecular Medicine, vol. 48, no. 5, article e231, 2016. View at Publisher · View at Google Scholar
  46. R. Garcia, T. L. Bowman, G. Niu et al., “Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells,” Oncogene, vol. 20, no. 20, pp. 2499–2513, 2001. View at Publisher · View at Google Scholar · View at Scopus